Sit Investment Associates Inc Seres Therapeutics, Inc. Transaction History

Sit Investment Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $186,108 - $404,966	79,875 Added 30.45%	342,200 $814,000
Q1 2023 May 11, 2023	SELL	$4.95 - $6.09 $13,241 - $16,290	-2,675 Reduced 1.01%	262,325 $1.49 Million
Q4 2022 Feb 10, 2023	BUY	$5.09 - $9.05 $335,940 - $597,300	66,000 Added 33.17%	265,000 $1.48 Million
Q2 2022 Aug 11, 2022	BUY	$2.7 - $7.62 $368,685 - $1.04 Million	136,550 Added 218.65%	199,000 $683,000
Q2 2021 Aug 13, 2021	BUY	$18.46 - $24.36 $1.15 Million - $1.52 Million	62,450 New	62,450 $1.49 Million

41M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $104M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.